HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marc Humbert Selected Research

Dexfenfluramine (Redux)

12/2022Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.
10/2011Pulmonary arterial hypertension in a patient with Cowden syndrome and anorexigen exposure.
5/2008Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marc Humbert Research Topics

Disease

181Pulmonary Arterial Hypertension
12/2022 - 01/2002
119Pulmonary Hypertension
03/2022 - 03/2002
55Asthma (Bronchial Asthma)
11/2022 - 12/2003
34Familial Primary Pulmonary Hypertension
07/2021 - 02/2002
33Hypoxia (Hypoxemia)
01/2022 - 12/2009
28Inflammation (Inflammations)
12/2021 - 12/2003
23Vascular Remodeling
01/2022 - 12/2005
15Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary)
01/2021 - 03/2002
13Connective Tissue Diseases (Connective Tissue Disease)
02/2017 - 01/2004
12Neoplasms (Cancer)
01/2022 - 07/2010
12Systemic Scleroderma (Systemic Sclerosis)
12/2019 - 06/2007
11Fibrosis (Cirrhosis)
11/2021 - 08/2002
10Heart Failure
01/2022 - 08/2002
9Infections
01/2020 - 01/2004
8Hypertrophy
01/2021 - 09/2002
7Hypertension (High Blood Pressure)
11/2021 - 01/2006
7Congenital Heart Defects (Congenital Heart Defect)
10/2021 - 01/2004
7Lung Diseases (Lung Disease)
01/2021 - 02/2008
6Interstitial Lung Diseases (Interstitial Lung Disease)
10/2021 - 08/2011
6Rare Diseases (Rare Disease)
01/2021 - 01/2002
6Disease Progression
01/2021 - 05/2010
6Right Ventricular Hypertrophy
01/2020 - 01/2013
6Chronic Obstructive Pulmonary Disease (COPD)
01/2019 - 02/2010
6Hyperplasia
08/2011 - 03/2002
5COVID-19
04/2022 - 01/2020
5Sarcoidosis (Schaumann Disease)
01/2021 - 06/2012
5Portal Hypertension
12/2019 - 01/2004
5Pulmonary Edema
10/2017 - 07/2008
5HIV Infections (HIV Infection)
10/2013 - 12/2004
4Hemorrhage
01/2021 - 01/2010
4Pleural Effusion (Pleural Effusions)
10/2020 - 03/2002
4Dyspnea (Shortness of Breath)
12/2019 - 06/2008
4Allergic Rhinitis
05/2019 - 12/2003
4Hereditary Hemorrhagic Telangiectasia
10/2014 - 12/2005

Drug/Important Bio-Agent (IBA)

33Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 10/2004
29MonocrotalineIBA
01/2022 - 12/2009
24Epoprostenol (Prostacyclin)FDA LinkGeneric
12/2019 - 02/2002
15riociguatIBA
01/2022 - 07/2013
15Vasodilator Agents (Vasodilators)IBA
08/2021 - 02/2002
14Omalizumab (Xolair)FDA Link
11/2022 - 01/2008
14Bosentan (Tracleer)FDA Link
01/2021 - 12/2004
14CytokinesIBA
01/2021 - 02/2002
13Endothelin Receptor AntagonistsIBA
07/2020 - 12/2004
12Pharmaceutical PreparationsIBA
01/2022 - 12/2005
12Monoclonal AntibodiesIBA
01/2021 - 01/2008
12Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
01/2021 - 06/2008
10Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2012
10Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 02/2002
9Dasatinib (BMS 354825)FDA Link
12/2022 - 05/2012
9ProstaglandinsIBA
01/2022 - 09/2002
9Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2005
9mepolizumabIBA
01/2022 - 07/2014
9Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2021 - 06/2002
9Immunoglobulin E (IgE)IBA
01/2021 - 08/2013
8Oxygen (Dioxygen)IBA
04/2022 - 08/2002
7Biological ProductsIBA
12/2022 - 08/2013
7Carbon MonoxideIBA
01/2021 - 01/2010
7AntibodiesIBA
01/2019 - 01/2008
7Sildenafil Citrate (Viagra)FDA Link
01/2018 - 01/2004
7Serotonin (5 Hydroxytryptamine)IBA
02/2017 - 10/2002
7ChemokinesIBA
06/2014 - 02/2002
6Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2013
6SteroidsIBA
01/2021 - 02/2007
6Soluble Guanylyl CyclaseIBA
01/2021 - 07/2013
6Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
12/2019 - 01/2013
6Endothelins (Endothelin)IBA
12/2014 - 12/2004
6Transforming Growth Factor beta (TGF-beta)IBA
01/2014 - 01/2002
5Appetite Depressants (Anorectics)IBA
12/2022 - 01/2004
5pro-brain natriuretic peptide (1-76)IBA
01/2022 - 01/2007
5Platelet-Derived Growth FactorIBA
01/2022 - 07/2008
5Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2021 - 09/2015
5anti-IgE antibodiesIBA
01/2021 - 01/2008
5Phosphodiesterase 5 InhibitorsIBA
01/2020 - 09/2009
5Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2020 - 09/2006
5Endothelin-1 (Endothelin 1)IBA
01/2019 - 08/2005
5Phosphotransferases (Kinase)IBA
01/2018 - 10/2012
4FenfluramineIBA
12/2022 - 06/2005
4AnticoagulantsIBA
03/2022 - 11/2016
4ProteomeIBA
01/2022 - 10/2016
4Messenger RNA (mRNA)IBA
11/2021 - 02/2002
4LeptinIBA
01/2021 - 10/2012
4GlucocorticoidsIBA
01/2020 - 02/2008
4Tadalafil (Cialis)FDA Link
12/2019 - 09/2009
4Tyrosine Kinase InhibitorsIBA
01/2018 - 06/2009
4Interleukin-5 (Interleukin 5)IBA
01/2018 - 09/2013
4activin receptor type II-A (activin A receptor, type II)IBA
01/2017 - 04/2010
4Transcription Factors (Transcription Factor)IBA
11/2016 - 01/2013
4InterferonsIBA
01/2016 - 02/2014
4AutoantibodiesIBA
06/2013 - 09/2007
4Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
12/2009 - 03/2002
3Dexfenfluramine (Redux)IBA
12/2022 - 05/2008
3Amphetamine (Amfetamine)FDA LinkGeneric
12/2022 - 01/2018
3benfluorex (S 780)IBA
12/2022 - 04/2010

Therapy/Procedure

104Therapeutics
03/2022 - 03/2002
19Lung Transplantation
01/2022 - 09/2002
13Endarterectomy (Thromboendarterectomy)
03/2022 - 09/2006
8Transplantation
10/2021 - 03/2006
6Drug Therapy (Chemotherapy)
01/2019 - 01/2015
5Heart-Lung Transplantation
10/2021 - 10/2012
3Biological Therapy
12/2021 - 01/2017